Summary
This Eli Lilly & Co. (LLY) Form 8-K, filed on March 13, 2002, primarily serves to provide essential financial information incorporated by reference into a prospectus supplement related to the company's 6.00% Notes due 2012. The filing includes updated financial statements and management's discussion and analysis, which are critical for investors to assess the company's financial health and operational performance in conjunction with the debt offering. While this filing doesn't announce new operational developments or significant strategic shifts, its core purpose is to ensure transparency and compliance for the debt issuance. Investors interested in LLY's debt offerings should review the incorporated financial data and the accompanying prospectus for a comprehensive understanding of the company's financial standing and the terms of the notes.
Key Highlights
- 1Eli Lilly & Co. (LLY) filed a Form 8-K on March 13, 2002.
- 2The filing is primarily related to a prospectus and prospectus supplement for the issuance of 6.00% Notes due 2012.
- 3Key financial documents are incorporated by reference into the prospectus.
- 4Included exhibits are: Statement Regarding Computation of Ratio of Earnings From Continuing Operations to Fixed Charges, Consent of Independent Auditors, Audited Consolidated Financial Statements, and Management's Discussion and Analysis.
- 5The filing does not appear to contain new, significant operational announcements, but rather focuses on financial disclosure for a debt offering.
- 6Thomas W. Grein, Vice President and Treasurer, signed the report.